Hydrogen sulfide in posthemorrhagic shock mesenteric lymph drainage alleviates kidney injury in rats

Braz J Med Biol Res. 2015 Jul;48(7):622-8. doi: 10.1590/1414-431X20154057. Epub 2015 Apr 28.

Abstract

Posthemorrhagic shock mesenteric lymph (PHSML) is a key factor in multiple organ injury following hemorrhagic shock. We investigated the role of hydrogen sulfide (H2S) in PHSML drainage in alleviating acute kidney injury (AKI) by administering D,L-propargylglycine (PPG) and sodium hydrosulfide hydrate (NaHS) to 12 specific pathogen-free male Wistar rats with PHSML drainage. A hemorrhagic shock model was established in 4 experimental groups: shock, shock+drainage, shock+drainage+PPG (45 mg/kg, 0.5 h prehemorrhage), and shock+drainage+NaHS (28 µmol/kg, 0.5 h prehemorrhage). Fluid resuscitation was performed after 1 h of hypotension, and PHMSL was drained in the last three groups for 3 h after resuscitation. Renal function and histomorphology were assessed along with levels of H2S, cystathionine-γ-lyase (CSE), Toll-like receptor 4 (TLR4), interleukin (IL)-10, IL-12, and tumor necrosis factor (TNF)-α in renal tissue. Hemorrhagic shock induced AKI with increased urea and creatinine levels in plasma and higher H2S, CSE, TLR4, IL-10, IL-12, and TNF-α levels in renal tissue. PHSML drainage significantly reduced urea, creatinine, H2S, CSE, and TNF-α but not TLR4, IL-10, or IL-12. PPG decreased creatinine, H2S, IL-10, and TNF-α levels, but this effect was reversed by NaHS administration. In conclusion, PHSML drainage alleviated AKI following hemorrhagic shock by preventing increases in H2S and H2S-mediated inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Kidney Injury / physiopathology
  • Acute Kidney Injury / prevention & control*
  • Alkynes / therapeutic use
  • Animals
  • Creatinine / blood
  • Cystathionine gamma-Lyase / analysis
  • Cytokines / analysis
  • Drainage / methods*
  • Enzyme Inhibitors / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Gasotransmitters / analysis
  • Gasotransmitters / therapeutic use*
  • Glycine / analogs & derivatives
  • Glycine / therapeutic use
  • Hydrogen Sulfide / analysis
  • Hydrogen Sulfide / therapeutic use*
  • Lymph / physiology*
  • Male
  • Mesentery
  • Rats, Wistar
  • Reproducibility of Results
  • Shock, Hemorrhagic / complications
  • Shock, Hemorrhagic / therapy*
  • Sulfites / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Urea / blood

Substances

  • Alkynes
  • Cytokines
  • Enzyme Inhibitors
  • Gasotransmitters
  • Sulfites
  • propargylglycine
  • Urea
  • sodium hydrogen sulfite
  • Creatinine
  • Cystathionine gamma-Lyase
  • Glycine
  • Hydrogen Sulfide